Journal News

Starved to death: Can dietary methionine combat cancer?

Nicole Lynn
July 27, 2021

The organic compounds that come together to form proteins are called amino acids. The human body uses amino acids as sources of energy for functions such as homeostasis, growth, and repair. While the body can produce some amino acids (known as nonessential), others are strictly obtained through food (known as essential).

The essential amino acid methionine, or Met, is critical for genetic regulation, protein production, cell metabolism and DNA repair. Unlike noncancerous cells, most cancer cells cannot recycle Met efficiently; instead, cancer cells rely on a continuous supply of methionine from external sources for growth. This vulnerability is known as Met dependence, or Met stress sensitivity.

Researchers do not know much yet about the mechanisms behind Met dependence in cancer; however, a recent study published in the Journal of Lipid Research has brought us closer to understanding the role of Met dependence in cancer cell lipid metabolism. Peter Kaiser of the University of California, Irvine, and collaborators at the University of California, Davis, Metabolomics Center and University of Texas MD Anderson Cancer Center used Met-dependent and Met-independent breast cancer cell lines to characterize the lipid changes that occur in response to Met-dependent stress.

Kaiser Group, University of California, Irvine
This image shows cancer cells (red) starved of methionine. The stress of this deficiency results in accumulation of lipid droplets (yellow) in the cell.

In the cell, diverse lipids make up the cellular membrane and aid in signaling and transport; lipids are also important for nutrient and energy storage. While lipid metabolism is studied widely in relationship to heart disease, researchers know little about lipid metabolism in cancer.

“In cancers, specifically in breast cancer, there has always been a connection to lipid metabolism,” Kaiser said. “We are very interested in understanding how these changes in lipids can affect cancer cells and how they can translate into feasible drug targets.”

Kaiser and colleagues fed cancer cells Met-deficient media to induce stress and then used high-performance liquid chromatography, genetic analysis, and cell microscopy to characterize the changes that occurred in lipids. The researchers found that lipid remodeling and abundance are affected directly by Met-deprivation stress in cancer cells.

Compared to the Met-independent cells (which do not require externally provided Met), the researchers saw an accumulation of lipid droplets, a decrease in lipid synthesis, and a global decrease in all lipid types (except triglycerides; these underwent remodeling), in the Met-dependent cancer cells (which require a continuous external supply of Met). These changes suggest Met stress may affect the endoplasmic reticulum, or ER, an organelle in the cell responsible for many metabolic processes, including lipid synthesis.

“A lot of proteins are folded in the ER,” Kaiser said. “This can lead to a stress response because protein folding becomes impacted in the ER as a consequence of the changes occurring to the lipids.”

These findings support a previous study in which reduced dietary Met helped shrink tumors in rats when used in conjunction with radiation or chemotherapeutics.

Kaiser and his colleagues seek to understand the molecular mechanisms involved in cancer Met dependence. His lab is also interested in the relationship between Met dependence and cell cycle regulation. These studies could increase knowledge of the unique metabolic needs of cancer cells and lead to better therapies.

Nicole Lynn

Nicole Lynn is a Ph.D. candidate at UCLA and a volunteer writer for ASBMB Today.

Related articles

From the journals: March 2019
John Arnst, Courtney Chandler, Isha Dey & Catherine Goodman
From the journals: August 2018
John Arnst, Sasha Mushegian, Angela Hopp & Laurel Oldach
A surprising modification lowers the lipid binding affinity of a membrane trafficking protein
Jefferson Knight, Colin T. Shearn & Cisloynny Beauchamp–Pérez

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Science

Science highlights or most popular articles

Finding the right research path
Interview

Finding the right research path

Sept. 16, 2021

Karen Bornfeldt, an associate editor for the Journal of Lipid Research, investigates how diabetes increases cardiovascular disease risk.

From the journals: JBC
Journal News

From the journals: JBC

Sept. 15, 2021

Antibody interactions that change cytotoxicity. An atlas for macrophage activation. Anti–Zika virus natural products. Read about papers on these and other topics.

Noboru Sueoka (1929 – 2021)
Retrospective

Noboru Sueoka (1929 – 2021)

Sept. 13, 2021

Sueoka made widely known contributions to our understanding of DNA replication. Indeed, he coined the term “origin of replication.”

From CRISPR to glowing proteins to optogenetics
Feature

From CRISPR to glowing proteins to optogenetics

Sept. 12, 2021

Three pioneering technologies have forever altered how researchers do their work and promise to revolutionize medicine, from correcting genetic disorders to treating degenerative brain diseases.

Lobsters hold the secret of a long, cancer-free life in their genes
News

Lobsters hold the secret of a long, cancer-free life in their genes

Sept. 11, 2021

More than a mere delicacy, the humble lobster could teach us a lot about healthy aging.

Personal chemistry: Proteomics tackles privacy concerns
Feature

Personal chemistry: Proteomics tackles privacy concerns

Sept. 9, 2021

Sharing raw data is an important norm for the proteomics community. But as clinical studies become more detailed, researchers may need to clamp down to protect patient privacy.